title: Suppression of cAMP formation by adenosine in myenteric ganglia from guinea-pig small intestine.
abstract: Effects of the adenosine receptor agonist 2-chloro-N6-cyclopentyl-adenosine (CCPA) on stimulation of cAMP formation by histamine, 5-hydroxytryptamine, substance P and forskolin were determined for enzymatically dissociated ganglia from the myenteric plexus of guinea-pig small intestine. Each of the 4 substances stimulated cAMP production. CCPA blocked the stimulation of cAMP by histamine, but not by 5-hydroxytryptamine or substance P. CCPA marginally suppressed stimulation by forskolin. CCPA alone suppressed basal levels of cAMP. The adenosine receptor antagonist 8-cyclopentyl-1,3-dimethylxanthine (CPT) reversed the inhibitory action of CCPA on stimulation of cAMP formation by histamine. Exposure to adenosine deaminase or CPT increased cAMP in the ganglia. The results are consistent with a hypothesis that stimulation of adenylate cyclase and elevation of intraneuronal cAMP in enteric neurons are steps in the signal transduction cascade for the excitatory actions of 5-hydroxytryptamine, substance P and histamine. They are consistent also with an original hypothesis from electrophysiologic studies which states that stimulation of adenosine A1 receptors suppresses cAMP formation and thereby slow synaptic excitation in response to histamine, but not to 5-hydroxytryptamine or substance P. The results support evidence from intracellular microelectrode studies which suggested that endogenous adenosine accumulates to levels sufficient for tonic suppression of cAMP formation in myenteric ganglia in vitro.
authors.affiliation: Department of Physiology, College of Medicine, Ohio State University, Columbus 43210-1239, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Xia
authors.forename: R H
authors.initials: RH
authors.lastname: Fertel
authors.forename: J D
authors.initials: JD
authors.lastname: Wood
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D000243:Adenosine Deaminase / Q000378:metabolism; D000818:Animals; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000037:antagonists & inhibitors*; D004336:Drug Antagonism; D005724:Ganglia / Q000201:enzymology / Q000378:metabolism*; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007421:Intestine, Small / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D009197:Myenteric Plexus / Q000201:enzymology / Q000378:metabolism*; D058906:Purinergic P1 Receptor Agonists; D012701:Serotonin / Q000494:pharmacology; D015398:Signal Transduction; D013268:Stimulation, Chemical; D013373:Substance P / Q000494:pharmacology
chemical_list: D058906:Purinergic P1 Receptor Agonists; C075256:2-(3-cyclopentyl-1-propyn-1-yl)adenosine; D005576:Colforsin; D012701:Serotonin; D013373:Substance P; D006632:Histamine; D000242:Cyclic AMP; D000243:Adenosine Deaminase; D000241:Adenosine